A patent medicine is a proprietary medicine made and marketed under a patent and is owned by an individual company. Patent medicine means that only the pharmaceutical company that holds the patent is allowed to manufacture and make profit out of it. In most cases, drug patent is awarded for 20 years to pharmaceutical companies.
MARKET DYNAMICS
The patent medicine market is driving due to increasing prevalence of diseases worldwide, and increasing research and development activities globally. However, high cost of patent medicine as compared to generic medicine is expected to hamper the growth of the global patent medicine market. Moreover, increasing pipeline of patented drugs is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Patent Medicine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Patent Medicine market with detailed market segmentation by medicine type, and indication. The Patent Medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Patent Medicine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Patent Medicine market is segmented based on medicine type, and indication. Based on medicine type, the market is segmented into solid drug products, semi-solid drug products, liquid drug products, gas/aerosols drug products, others. Based on indication, the market is segmented into cardiovascular disease, respiratory disease, immunological disease, blood disease, gastrointestinal disease, ophthalmic disease, orthopedic disease, neurodegenerative disease, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Patent Medicine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Patent Medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Patent Medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Patent Medicine market in these regions.
MARKET PLAYERS
The report covers key developments in the Patent Medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Patent Medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Patent Medicine market in the global market. Below mentioned is the list of few companies engaged in the Patent Medicine market.
The report also includes the profiles of key players in Patent Medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Otsuka Pharmaceutical Co., Ltd.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- Roche Holding AG
- Amgen Inc.
- AbbVie Inc.
- Sanofi
- Bristol-Myers Squibb Company
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.